Related Experiment Video

Updated: Jun 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Dyslipidemia and abdominal aortic aneurysm: another piece of the puzzle?

Turgay Celik, Atila Iyisoy, Murat Celik

    International Journal of Cardiology
    |September 23, 2008
    PubMed

    Insights

    The cause of aortic aneurysms remains unclear, but research suggests a systemic issue with vascular proteins, not atherosclerosis, is the primary driver. Atherosclerosis may develop as a consequence of this underlying vascular defect.

    Area of Science:

    • Cardiovascular Research
    • Genetics and Molecular Biology
    • Vascular Medicine

    Background:

    • The etiology of aneurysmal aortic dilation is largely unknown in most patients.
    • The relationship between atherosclerosis and aortic aneurysms is debated, with uncertainty regarding causality.
    • Familial clustering suggests a potential genetic component in the development of aortic aneurysms.

    Discussion:

    • Emerging evidence supports a multifactorial, systemic, and nonatherosclerotic hypothesis for aneurysm development.
    • A primary defect in vascular structural proteins is proposed as a key causal factor.
    • Atherosclerosis is increasingly viewed as a secondary process rather than the root cause.

    Key Insights:

    • Aortic aneurysms may stem from inherent weaknesses in blood vessel structural proteins.
    • Systemic factors, independent of atherosclerosis, are likely central to aneurysm pathogenesis.
    • Genetic predisposition could play a significant role in susceptible individuals.

    Outlook:

    • Further research into vascular protein defects could reveal novel therapeutic targets.
    • Understanding the systemic nature of aneurysmal disease is crucial for effective management.
    • Distinguishing primary aneurysm causes from secondary conditions like atherosclerosis is vital for accurate diagnosis and treatment.

    Related Concept Videos

    Atherosclerosis I: Introduction01:30

    Atherosclerosis I: Introduction

    Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Peripheral Artery Disease I: Introduction01:30

    Peripheral Artery Disease I: Introduction

    Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

    Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

    Aneurysm II: Clinical Manifestations and Diagnostic Studies

    Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...